Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2077-2021Class II

BULKAMID, URETHRAL BULKING SYSTEM model # 50050 containing the component: Bulkamid Needle, REF 230651221C, 2...

Axonics, Inc. / initiated 2021-06-03 / Terminated / root cause: manufacturing process

Axonics Modulation Technologies, Inc. began a recall of BULKAMID, URETHRAL BULKING SYSTEM model # 50050 containing the component: Bulkamid Needle, REF 230651221C, 2 G x 12 am, sterile, CE 0476 on . FDA classified it as Class II and gives the reason as "Lack of Sterility Assurance; needle in procedure pack labeled as sterile may not have been adequately sterilized". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2077-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Axonics, Inc.
Product
BULKAMID, URETHRAL BULKING SYSTEM model # 50050 containing the component: Bulkamid Needle, REF 230651221C, 2 G x 12 am, sterile, CE 0476
Product code
LNM Agent, Bulking, Injectable For Gastro-Urology Use
Reason for recall
Lack of Sterility Assurance; needle in procedure pack labeled as sterile may not have been adequately sterilized
Root cause tag
manufacturing process
FDA root cause
Material/Component Contamination
Action
On June 3, 2021 Axonics issued "Medical Device Recall" to all consignees via FedEx. In addition to informing consignees about the recalled product, the firm asked customers to take following actions: 1. Immediately review your inventory for the Lot No. specified in this notification and share this notice and Customer Response Form with appropriate staff. 2. If you further distributed this product, please notify those entities of this product recall. Please include a copy of this recall notification in your communication. 3. Quarantine and then discard any units of the impacted lots. Axonics will provide replacement product at no cost. 4. Complete and return the Customer Response Form within 10 working days to [email protected] so that we are assured you have received this important communication. 5. Report any adverse health consequences with the use of this product to Axonics or to the FDAs MedWatch Adverse Event Reporting program 6.If there are any questions, please email to [email protected] or call Axonics Customer Service at 1-877-929-6642 Action Taken by Axonics: 1. An alternate contract sterilization facility has already been qualified and is now being employed. 2. If you have any product from any of these lots, Axonics will replace the product at no cost. 3. Axonics will prioritize the replacement of product to customers affected by the recall and we respectfully request that you complete the Customer Response Form
Quantity in commerce
2,702 units
Distribution
US nationwide distribution.
Product codes and lots
Lot numbers: 19F0901AA, 19F0902AA, 19F0903AA, 19F0904AA, 19F0905AA, 19F0906AA

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2077-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2077-2021Class IITerminatedVoluntary: Firm initiated